Biorepository for breast cancer survivors
A Comprehensive Breast Cancer Survivorship Biorepository
This study is collecting blood samples and health information from women who have survived early to moderate stage breast cancer to help with future research on survivorship.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1300 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Southern California Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT05786664 on ClinicalTrials.gov |
What this trial studies
This study collects blood samples and clinical data from women who have survived stage I-III breast cancer to create a biorepository for future research. The primary goal is to gather annotated blood samples, while secondary objectives include collecting data on social determinants of health, environmental exposures, and lifestyle factors. Participants will complete surveys, undergo blood sample collection, and have their medical records reviewed to support ongoing and future studies related to breast cancer survivorship.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 and older who have been diagnosed with invasive breast cancer stages I-III within the past 7 years and have completed their active treatment.
Not a fit: Patients currently participating in interventional clinical trials or those with stage IV cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this biorepository could enhance understanding of breast cancer outcomes and inform future treatment strategies.
How similar studies have performed: Other studies have successfully utilized biorepositories for cancer research, indicating a promising approach for this initiative.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women of all racial and ethnic groups 18 years of age or older * Women with a diagnosis of invasive breast cancer (stages I-III) within the past 7 years * Women who have completed active treatment for breast cancer (surgery, chemotherapy, HER2-directed therapy and radiation) * Prior participation on clinical trials is allowed Exclusion Criteria: * Current receipt of interventional clinical trial participation * Stage IV (metastatic) cancer * Prior history of recurrence (except recurrence following ductal carcinoma in situ) * Inability to give informed consent * Unable to speak English, Spanish, Chinese, or Korean
Where this trial is running
Los Angeles, California
- USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States (Recruiting)
Study contacts
- Principal investigator: Bodour Salhia, PhD — University of Southern California
- Study coordinator: Audrey Saghian, MPH
- Email: amsaghia@usc.edu
- Phone: 323-865-6086
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.